Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test could help tailor breast cancer treatment, potentially sparing some patients stronger drugs

NCT ID NCT07214532

Summary

This study is testing a personalized approach for people with a specific type of early-stage breast cancer. It uses a blood test to check for tiny signs of cancer. Based on the test result, participants either continue standard hormone therapy or add a stronger drug to it. The goal is to see if this guided approach can keep cancer under control while reducing unnecessary treatment for some.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.